Johnson & Johnson (JNJ) Shares Sold by Farmers & Merchants Investments Inc.
Farmers & Merchants Investments Inc. reduced its position in Johnson & Johnson (NYSE:JNJ) by 0.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 145,340 shares of the company’s stock after selling 964 shares during the quarter. Johnson & Johnson makes up about 1.6% of Farmers & Merchants Investments Inc.’s holdings, making the stock its 9th largest position. Farmers & Merchants Investments Inc.’s holdings in Johnson & Johnson were worth $19,227,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Lenox Wealth Advisors Inc. increased its position in Johnson & Johnson by 0.7% in the first quarter. Lenox Wealth Advisors Inc. now owns 871 shares of the company’s stock worth $108,000 after buying an additional 6 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. increased its position in Johnson & Johnson by 241.0% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,190 shares of the company’s stock worth $149,000 after buying an additional 841 shares during the last quarter. Ullmann Financial Group Inc. purchased a new stake in Johnson & Johnson in the first quarter worth $186,000. Taylor Wealth Management Partners increased its position in Johnson & Johnson by 19.8% in the first quarter. Taylor Wealth Management Partners now owns 1,510 shares of the company’s stock worth $188,000 after buying an additional 250 shares during the last quarter. Finally, Foundation Resource Management Inc. purchased a new stake in Johnson & Johnson in the first quarter worth $204,000. 66.00% of the stock is owned by institutional investors and hedge funds.
Several equities analysts have recently weighed in on the company. BidaskClub upgraded Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 17th. Royal Bank Of Canada reiterated a “buy” rating and issued a $128.00 price target on shares of Johnson & Johnson in a research report on Thursday, June 15th. Atlantic Securities cut Johnson & Johnson from a “neutral” rating to an “underweight” rating and set a $113.00 price target for the company. in a research report on Friday, July 21st. Jefferies Group LLC reiterated a “hold” rating and issued a $145.00 price target (up from $140.00) on shares of Johnson & Johnson in a research report on Friday, July 14th. Finally, Morgan Stanley lifted their price target on Johnson & Johnson from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Wednesday, July 5th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $134.60.
In other Johnson & Johnson news, VP Dominic J. Caruso sold 82,591 shares of the stock in a transaction on Thursday, July 20th. The stock was sold at an average price of $136.72, for a total value of $11,291,841.52. Following the completion of the sale, the vice president now owns 226,693 shares in the company, valued at approximately $30,993,466.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Paulus Stoffels sold 102,692 shares of the stock in a transaction on Monday, July 24th. The stock was sold at an average price of $133.14, for a total value of $13,672,412.88. Following the completion of the sale, the vice president now owns 230,342 shares of the company’s stock, valued at approximately $30,667,733.88. The disclosure for this sale can be found here. Corporate insiders own 0.19% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Johnson & Johnson (JNJ) Shares Sold by Farmers & Merchants Investments Inc.” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/16/johnson-johnson-jnj-shares-sold-by-farmers-merchants-investments-inc.html.
Johnson & Johnson (NYSE:JNJ) traded up 0.20% during midday trading on Friday, reaching $134.45. The company had a trading volume of 15,522,011 shares. Johnson & Johnson has a 52 week low of $109.32 and a 52 week high of $137.08. The firm has a 50-day moving average price of $132.62 and a 200-day moving average price of $129.18. The company has a market capitalization of $360.86 billion, a price-to-earnings ratio of 22.75 and a beta of 0.79.
Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings results on Tuesday, July 18th. The company reported $1.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.79 by $0.04. Johnson & Johnson had a return on equity of 26.76% and a net margin of 22.52%. The business had revenue of $18.84 billion during the quarter, compared to analyst estimates of $18.94 billion. During the same quarter in the prior year, the business posted $1.74 EPS. Johnson & Johnson’s revenue for the quarter was up 1.9% compared to the same quarter last year. Analysts expect that Johnson & Johnson will post $7.18 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Tuesday, August 29th were paid a $0.84 dividend. The ex-dividend date was Friday, August 25th. This represents a $3.36 dividend on an annualized basis and a yield of 2.50%. Johnson & Johnson’s payout ratio is presently 56.76%.
Johnson & Johnson Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Stock Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related stocks with our FREE daily email newsletter.